Alerts will be sent to your verified email
Verify Email
WOCKPHARMA
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Wockhardt Limited is a prominent Indian pharmaceutical and biotechnology company that prioritizes accessibility to high-quality medicines. They are active in Pharmaceuticals, Biotechnology, and Super Speciality Hospitals.
Wockhardt major competitors are Pfizer, Eris Lifesciences, Astrazeneca Pharma I, JB Chem & Pharma, Alembic Pharma, Jubilant Pharmova, Caplin Point Lab.
Market Cap of Wockhardt is ₹23,019 Crs.
While the median market cap of its peers are ₹21,879 Crs.
Wockhardt seems to be less financially stable compared to its competitors.
Altman Z score of Wockhardt is 5.57 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun | Mar Jun Sep Dec | Jun Sep Dec | ||||
| Investor Presentation | Jun | Sep Dec | Dec | Mar Dec | Dec | Mar | Mar Jun Sep Dec | Mar Jun Dec | Mar Jun Sep Dec | Jun Sep Dec | ||||||||
| Conference Call | Mar | Dec | Mar Jun | Mar Nov | Jun Sep Dec | Sep Dec | ||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
